Skip to main content
SkinCited

Nicotinamide per UV Protection (Internal Photoprotection)

A Evidenze Più grandi trial clinici mostrano in modo costante benefici significativi.

At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dnicotinamide\u0026condition\u003Duv\u002Dprotection'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).

Key Study Findings

Review
The adverse effects of oral niacin/nicotinamide - an overview of reviews.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Overview of reviews on niacin/nicotinamide adverse effects

Meta-Analysis
The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
Dose: Nicotinamide (vitamin B3) vs: Placebo Outcome: AK and NMSC incidence reduction Effetto: None None

Popolazione: High-risk NMSC patients (RCTs)

Other
Nicotinamide: An Update and Review of Safety & Differences from Niacin.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Review
Final report of the safety assessment of niacinamide and niacin.
Dose: Niacinamide up to 5%; Niacin up to 0.1% vs: None Outcome: Safety assessment for cosmetic use Effetto: Safe as used in cosmetics None

Popolazione: General population (cosmetic users)

Key Statistics

5

Studi

686

Partecipanti

Positive

A

Grado

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

generalskinbarrier:
500-1,500 mg/day
skincancerchemoprevention:
500 mg twice daily (1,000 mg/day total)

Limite massimo: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Mixed --
Nicotinamide (vitamin B3) -- Positive --
None -- Mixed --
None -- Mixed --
Niacinamide up to 5%; Niacin up to 0.1% -- Mixed --

Momento migliore per l'assunzione: With meals; split into 2 doses for chemoprevention

Safety & Side Effects

Effetti collaterali segnalati

  • Generally well-tolerated (no flushing)
  • Mild gastrointestinal discomfort at high doses
  • Rare hepatotoxicity at very high doses

Interazioni note

  • Anticonvulsants (carbamazepine — may increase levels)
  • Isoniazid (competes for NAD+ pathways)
  • Hepatotoxic drugs (potential additive liver effect at high doses)

Livello di assunzione massimo tollerabile: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Nicotinamide help with UV Protection (Internal Photoprotection)?
Based on 5 studies with 686 participants, there is strong evidence from multiple clinical trials that Nicotinamide may support UV Protection (Internal Photoprotection) management. Our evidence grade is A (Strong Evidence).
How much Nicotinamide should I take for UV Protection (Internal Photoprotection)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Nicotinamide?
Reported side effects may include Generally well-tolerated (no flushing), Mild gastrointestinal discomfort at high doses, Rare hepatotoxicity at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Nicotinamide and UV Protection (Internal Photoprotection)?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 5 peer-reviewed studies with 686 total participants. The overall direction of effect is positive.

References

  1. [1] Su Ling Young et al.. Eye (Lond). 2025. The adverse effects of oral niacin/nicotinamide - an overview of reviews. doi:10.1038/s41433-025-04027-2 PubMed
  2. [2] Giulio Tosti et al.. Nutrients. 2023. The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis. doi:10.3390/nu16010100 PubMed
  3. [3] Katherine G Thompson et al.. J Am Acad Dermatol. 2021. Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium. doi:10.1016/j.jaad.2020.04.123 PubMed
  4. [4] Reed Huber et al.. Skin Therapy Lett. 2020. Nicotinamide: An Update and Review of Safety & Differences from Niacin. PubMed
  5. [5] Cosmetic Ingredient Review Expert Panel. Int J Toxicol. 2005. Final report of the safety assessment of niacinamide and niacin. doi:10.1080/10915810500434183 PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.